TNFR2 Agonism as a Sex-Specific Therapy for Novel Osteoarthritis-Induced Cardiac Dysfunction
Pranav Prasoon, Kelly Tammen, Rebekah Russo, Aravind Meyyappan, Manushri Dalvi, Román Fischer, Melanie Eschborn, Sreejita Arnab, Luke Brabbee, Lauren Schneider, Kayla L. Nguyen, David Mendelowitz, Matthew W. Kay, John R. Bethea
This study shows that TNFR2 agonism can prevent and reverse OA-induced cardiac dysfunction in female mice and delay systolic decline in males, revealing sex-specific cardiac effects of OA.
bioRxiv · Jul 23, 2026 · PreprintPhysiology